SRD MRD IIa
Research payments
$1,462,459
Through program year 2023, $1,462,459 in research payments was reported against SRD MRD IIa, across 67 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $944,923 | 30 |
| 2022 | Research | $517,457 | 36 |
| 2021 | Research | $80 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Christopher Devine Cincinnati, OH Named on 5 payments
- Dilsher Dhoot Valencia, CA Named on 4 payments
- Chirag Jhaveri Round Rock, TX Named on 3 payments
- Srinivas Sadda Pasadena, CA Named on 3 payments
- Suk Moon Lakeland, FL Named on 3 payments
- David Brown Cypress, TX Named on 3 payments
- Rima Patel Phoenix, AZ Named on 3 payments
- Stephen Huddleston Memphis, TN Named on 3 payments
- Baruch Kuppermann Irvine, CA Named on 2 payments
- David Almeida Erie, PA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.